These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28585280)

  • 21. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
    Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
    Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the crossover design in the presence of residual effects.
    Lehmacher W
    Stat Med; 1991 Jun; 10(6):891-9. PubMed ID: 1876779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Bayesian method for synthesizing evidence. The Confidence Profile Method.
    Eddy DM; Hasselblad V; Shachter R
    Int J Technol Assess Health Care; 1990; 6(1):31-55. PubMed ID: 2361818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.
    Bowden J; Tierney JF; Copas AJ; Burdett S
    BMC Med Res Methodol; 2011 Apr; 11():41. PubMed ID: 21473747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of population data analysis in on-farm dairy trials.
    Engstrom M; Sanchez W; Stone W; St-Pierre NR
    J Anim Sci; 2010 Apr; 88(13 Suppl):E25-31. PubMed ID: 19820048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal crossover designs for logistic regression models in pharmacodynamics.
    Waterhouse TH; Eccleston JA; Duffull SB
    J Biopharm Stat; 2006; 16(6):881-94. PubMed ID: 17146986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the designs of thorough QT/QTc clinical trials.
    Tsong Y
    J Biopharm Stat; 2013; 23(1):43-56. PubMed ID: 23331220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.
    Ishak KJ; Caro JJ; Drayson MT; Dimopoulos M; Weber D; Augustson B; Child JA; Knight R; Iqbal G; Dunn J; Shearer A; Morgan G
    Value Health; 2011; 14(5):672-8. PubMed ID: 21839405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating individualized treatment regimes from crossover designs.
    Nguyen CT; Luckett DJ; Kahkoska AR; Shearrer GE; Spruijt-Metz D; Davis JN; Kosorok MR
    Biometrics; 2020 Sep; 76(3):778-788. PubMed ID: 31743424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of hierarchical models for meta-analysis: experience in the metabolic ward studies of diet and blood cholesterol.
    Frost C; Clarke R; Beacon H
    Stat Med; 1999 Jul; 18(13):1657-76. PubMed ID: 10407236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximum likelihood estimation in meta-analytic structural equation modeling.
    Oort FJ; Jak S
    Res Synth Methods; 2016 Jun; 7(2):156-67. PubMed ID: 27286901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating intervention effects across different types of single-subject experimental designs: empirical illustration.
    Moeyaert M; Ugille M; Ferron JM; Onghena P; Heyvaert M; Beretvas SN; Van den Noortgate W
    Sch Psychol Q; 2015 Mar; 30(1):50-63. PubMed ID: 24884449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and analysis of crossover trials for absorbing binary endpoints.
    Nason M; Follmann D
    Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CrossOver: an algorithm for the construction of efficient cross-over designs.
    John JA; Russell KG; Whitaker D
    Stat Med; 2004 Sep; 23(17):2645-58. PubMed ID: 15316948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crossover design in pharmacy research.
    Cody RL; Slack MK
    Ann Pharmacother; 1992 Mar; 26(3):327-33. PubMed ID: 1532519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graphical methods for detecting bias in meta-analysis.
    Ferrer RL
    Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A matched crossover design for clinical trials.
    Simon LJ; Chinchilli VM
    Contemp Clin Trials; 2007 Sep; 28(5):638-46. PubMed ID: 17383239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.